11 Publikationen

Alle markieren

[11]
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382 OA
Borbély, A.N., et al., 2020. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry, 26(12), p 2602-2605.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[10]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495 OA
Borbély, A.N., et al., 2019. Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen, 8(6), p 737-742.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[9]
2019 | Dissertation | PUB-ID: 2937966
Borbély, A.N., 2019. Conjugates of Cryptophycin and RGD Peptides for Targeted Cancer Therapy, Bielefeld: Universität Bielefeld.
PUB
 
[8]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650 OA
Figueras Agustí, E., et al., 2019. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics, 11(5): 220.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[7]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762 OA
Borbély, A.N., et al., 2019. Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics, 11(4): 151.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[6]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897
Cazzamalli, S., et al., 2018. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega, 3(12), p 16743-16743.
PUB | DOI
 
[5]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953
Figueras Agustí, E., et al., 2018. Novel unit B cryptophycin analogues as payloads for targeted therapy. BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 14, p 1281-1286.
PUB | DOI | WoS | PubMed | Europe PMC
 
[4]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984
Cazzamalli, S., et al., 2018. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS OMEGA, 3(11), p 14726-14731.
PUB | DOI | WoS | PubMed | Europe PMC
 
[3]
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993
Borbély, A.N., et al., 2018. Novel Cryptophycin-based Conjugates for Tumor Targeting. In JOURNAL OF PEPTIDE SCIENCE. no.24 Hoboken: Wiley, pp. S59.
PUB | WoS
 
[2]
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996
Figueras Agustí, E., et al., 2018. Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle. In JOURNAL OF PEPTIDE SCIENCE. no.24 Hoboken: Wiley, pp. S166.
PUB | WoS
 
[1]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916981 OA
Weiss, C., et al., 2017. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. Journal of Peptide Science, 23(7-8), p 514-531.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 

Suche

Publikationen filtern

Darstellung / Sortierung

Zitationsstil: harvard1

Export / Einbettung

11 Publikationen

Alle markieren

[11]
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382 OA
Borbély, A.N., et al., 2020. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry, 26(12), p 2602-2605.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[10]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495 OA
Borbély, A.N., et al., 2019. Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen, 8(6), p 737-742.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[9]
2019 | Dissertation | PUB-ID: 2937966
Borbély, A.N., 2019. Conjugates of Cryptophycin and RGD Peptides for Targeted Cancer Therapy, Bielefeld: Universität Bielefeld.
PUB
 
[8]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650 OA
Figueras Agustí, E., et al., 2019. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics, 11(5): 220.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[7]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762 OA
Borbély, A.N., et al., 2019. Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics, 11(4): 151.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[6]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897
Cazzamalli, S., et al., 2018. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega, 3(12), p 16743-16743.
PUB | DOI
 
[5]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953
Figueras Agustí, E., et al., 2018. Novel unit B cryptophycin analogues as payloads for targeted therapy. BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 14, p 1281-1286.
PUB | DOI | WoS | PubMed | Europe PMC
 
[4]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984
Cazzamalli, S., et al., 2018. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS OMEGA, 3(11), p 14726-14731.
PUB | DOI | WoS | PubMed | Europe PMC
 
[3]
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993
Borbély, A.N., et al., 2018. Novel Cryptophycin-based Conjugates for Tumor Targeting. In JOURNAL OF PEPTIDE SCIENCE. no.24 Hoboken: Wiley, pp. S59.
PUB | WoS
 
[2]
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996
Figueras Agustí, E., et al., 2018. Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle. In JOURNAL OF PEPTIDE SCIENCE. no.24 Hoboken: Wiley, pp. S166.
PUB | WoS
 
[1]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916981 OA
Weiss, C., et al., 2017. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. Journal of Peptide Science, 23(7-8), p 514-531.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 

Suche

Publikationen filtern

Darstellung / Sortierung

Zitationsstil: harvard1

Export / Einbettung